Altimmune
ALT
34 hedge funds and large institutions have $51.1M invested in Altimmune in 2015 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 5 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
20% more capital invested
Capital invested by funds: $42.5M → $51.1M (+$8.55M)
6% less funds holding
Funds holding: 36 → 34 (-2)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
83% less call options, than puts
Call options by funds: $1K | Put options by funds: $6K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BIT
26
BlackRock Institutional Trust
San Francisco,
California
| $12K | +$11.1K | +22 | New |
|
27
Bank of America
Charlotte,
North Carolina
| $10K | -$32.3K | -64 | -78% |
|
28
Morgan Stanley
New York
| $4K | -$22.7K | -45 | -87% |
|
29
Citigroup
New York
| $4K | – | – | – |
|
30
Group One Trading
Chicago,
Illinois
| $4K | +$3.54K | +7 | New |
|
31
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$505 | +1 | +33% |
|
|
TRCT
32
Tower Research Capital (TRC)
New York
| $1K | -$505 | -1 | -50% |
|
|
AIG
33
American International Group
New York
| $540 | – | – | – |
|
34
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $5 | – | – | – |
|
35
M&T Bank
Buffalo,
New York
| – | -$98K | -200 | Closed |
|
|
CS
36
Credit Suisse
Zurich,
Switzerland
| – | -$42K | -85 | Closed |
|
|
OAM
37
Oxford Asset Management
Oxford,
United Kingdom
| – | -$33K | -66 | Closed |
|
|
VKH
38
Virtu KCG Holdings
New York
| – | -$17K | -35 | Closed |
|
|
GC
39
Globeflex Capital
San Diego,
California
| – | -$1K | -1 | Closed |
|
ALT Hedge Fund Activity: Q2 2015 in Review
34 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q2 2015, worth a combined $51.1M — up 20% from $42.5M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ALT and 3 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 8 added.
The largest buyer was Hudson Bay Capital Management, adding an estimated $2.18M. The largest seller was Perkins Capital Management, cutting an estimated $127K.
- 34 institutional investors held Altimmune (ALT) as of Q2 2015, down from 36 in Q1 2015.
- Funds reported $51.1M of Altimmune stock for Q2 2015, up 20% quarter-over-quarter.
- 3 funds opened new Altimmune positions in Q2 2015 and 5 closed out, a net change of -2 holders.
- The largest Altimmune buyer in Q2 2015 was Hudson Bay Capital Management, an estimated $2.18M added.
- The largest Altimmune seller in Q2 2015 was Perkins Capital Management, an estimated $127K sold.
Based on aggregated 13F filings for Q2 2015.